EdU assays demonstrated that miR-144-3p significantly inhibited TOP2A overexpression, followed by the reversed effect of TOP2A on the proliferation in HCC cells (Figure 7A and 7B). The gene discussed is TOP2A; the disease is hepatocellular carcinoma.